Mucormycosis and COVID‐19: An epidemic within a pandemic in India
Coronavirus disease (COVID-19) causes an immunosuppressed state and increases risk of secondary infections like mucormycosis. We evaluated clinical features, predisposing factors, diagnosis and outcomes for mucormycosis among patients with COVID-19 infection. This prospective, observational, multi-c...
Sparad:
Huvudupphovsmän: | , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Materialtyp: | Artigo |
Språk: | engelska |
Publicerad: |
2021
|
Länkar: | https://doi.org/10.1111/myc.13353 |
Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|